On September 11, 2025, Artelo Biosciences, Inc. announced the partial exercise of an over-allotment option from a previous stock offering, generating approximately $0.25 million in gross proceeds. This follows their earlier offering of 640,924 shares at $4.40 each, which closed on September 5, 2025, totaling about $3,000,000 before expenses.